接受经口机器人手术及辅助治疗的Head Neck癌症患者的短期与长期吞咽结局
本研究采用经验证的改良钡餐吞咽损伤量表(MBSImP),对37例因Head Neck癌症接受经口机器人手术(TORS)的患者在基线及术后两个时间点进行视频透视吞咽评估,发现患者在术后即刻及术后晚期生理性吞咽损伤加重,尤其气道保护相关成分受累明显,且许多患者基线时已存在吞咽损伤。作者指出需进一步研究以阐明治疗前后不同时间点及不同辅助治疗方案下的吞咽困难情况。
要点
- 37例Head Neck癌症患者接受TORS,采用MBSImP在基线及术后两个时间点评估吞咽。
- 术后即刻及术后晚期生理性吞咽损伤较基线加重,尤以气道保护相关成分为著。
- 许多患者在基线时即已存在吞咽损伤。
核心结论
- 接受TORS及辅助治疗的Head Neck癌症患者在术后即刻和术后晚期生理性吞咽损伤加重,尤其气道保护相关成分受累明显,许多患者基线时已有吞咽损伤。
- 作者认为需进一步研究以阐明治疗前后不同时间点的吞咽困难及不同且不断演变的辅助治疗方案下的情况。
研究设计与样本
- 对37例因Head Neck癌症接受TORS的患者进行视频透视吞咽研究评估,采用经验证的改良钡餐吞咽损伤量表(MBSImP),在包括基线在内的三个时间点进行评估。
主要发现
- 患者在术后即刻和术后晚期生理性吞咽损伤加重,尤其与气道保护相关的成分受累明显。
- 许多患者基线时也存在吞咽损伤。
局限性
- 作者指出需进一步研究以阐明治疗前后离散时间点的吞咽困难以及不同且不断演变的辅助治疗方案下的情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dysphagia (difficulty swallowing) is a common morbidity resulting from the treatment of head-and-neck squamous-cell carcinoma (HNSCC) due to surgery and chemoradiation. Transoral robotic surgery (TORS) is a minimally invasive surgical technique for the management of HNSCC, which ideally avoids many of the known complications of open surgery. Research describing physiologic swallowing impairment after surgery using videofluoroscopy is lacking. METHODS: We evaluated videofluoroscopic swallowing studies of 37 patients who received TORS for head and neck cancer using a validated scoring tool, the Modified Barium Swallow Impairment Profile (MBSImP), at three time points including baseline. RESULTS: Patients had worsened physiologic impairments in the immediate post-operative and late post-operative periods, particularly in components related to airway protection. Many patients also had baseline swallowing impairment. CONCLUSIONS: Further research is required to elucidate dysphagia at discrete time points before and after treatment as well as with different and evolving adjuvant therapy protocols.
引用
- Weiland AC, Samant S, Clain AE, et al. Short- and Long-Term Swallowing Outcomes in Head and Neck Cancer Patients Receiving TORS and Adjuvant Therapy. Head Neck. 2024. PMID: 39714099. doi:10.1002/hed.28033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。